These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1635219)

  • 1. [Miscellaneous factors on mechanisms of blood pressure regulation].
    Ushiogi Y; Takabatake T; Kobayashi K
    Nihon Rinsho; 1992 Apr; 50 Suppl():389-94. PubMed ID: 1635219
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid mediators of inflammation and allergy.
    O'Flaherty JT
    Lab Invest; 1982 Oct; 47(4):314-29. PubMed ID: 6126615
    [No Abstract]   [Full Text] [Related]  

  • 3. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat.
    Moreau P; de Champlain J; Yamaguchi N
    J Hypertens; 1992 Aug; 10(8):773-80. PubMed ID: 1325509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediators and asthma.
    Barnes PJ
    Br J Hosp Med; 1985 Dec; 34(6):339-44. PubMed ID: 3936563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vasoactive peptides in blood pressure control.
    Brunner HR
    J Hum Hypertens; 1993 Aug; 7(4):375-81. PubMed ID: 8410929
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of in vivo ketogenesis: role of free fatty acids and control by epinephrine, thyroid hormones, insulin and glucagon.
    Beylot M
    Diabetes Metab; 1996 Oct; 22(5):299-304. PubMed ID: 8896990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.
    Baltatzi M; Hatzitolios A; Tziomalos K; Iliadis F; Zamboulis Ch
    Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropeptide Y--a potential factor in blood pressure disease and vasospasm during parturition?].
    Härkönen M
    Duodecim; 1989; 105(13-14):1233-6. PubMed ID: 2670527
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of platelet-activating factor (PAF) on blood pressure, peripheral, coronary and renovascular system].
    Kawaguchi H; Takano H; Yasuda H
    Kokyu To Junkan; 1988 Aug; 36(8):819-25. PubMed ID: 3067285
    [No Abstract]   [Full Text] [Related]  

  • 10. [The pathophysiological role of the platelet activating factor].
    Shen YZ; Li CL
    Sheng Li Ke Xue Jin Zhan; 1991 Oct; 22(4):346-9. PubMed ID: 1796277
    [No Abstract]   [Full Text] [Related]  

  • 11. New targets for obesity pharmacotherapy.
    Aronne LJ; Thornton-Jones ZD
    Clin Pharmacol Ther; 2007 May; 81(5):748-52. PubMed ID: 17438540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y and hypertension.
    Thulin T; Erlinge D
    Nutrition; 1995; 11(5 Suppl):495-7. PubMed ID: 8748207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of thyroid hormones and prolactin in the development of disorders of arterial blood pressure in girls 11-12 years of age].
    Kolpakova GV; Volkova NG; Rozanov VB; Barsov DA; Chudakova IA
    Kardiologiia; 1989 May; 29(5):98-100. PubMed ID: 2770098
    [No Abstract]   [Full Text] [Related]  

  • 14. Paf-acether (platelet-activating factor).
    Benveniste J
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():11-8. PubMed ID: 3159192
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of lipolysis in adipose tissue.
    Meisner H; Carter JR
    Horiz Biochem Biophys; 1977; 4():91-129. PubMed ID: 202557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothyroidism and hypertension.
    Stabouli S; Papakatsika S; Kotsis V
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1559-65. PubMed ID: 21090931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelet aggregation and PAF-acether. Pharmacologic interference].
    Vargaftig BB; Fouque F; Lefort J
    J Pharmacol; 1984; 15 Suppl 1():69-84. PubMed ID: 6374298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-alpha-induced priming of human neutrophils.
    Stewart AG; Harris T
    Immunology; 1993 Jan; 78(1):152-8. PubMed ID: 8382188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor and anti-platelet-aggregating factor in acute reduction of blood pressure following percutaneous transluminal renal angioplasty in patients with renovascular hypertension.
    Masugi F; Ogihara T; Saeki S; Sakaguchi K; Kumahara Y
    J Hum Hypertens; 1988 Aug; 2(2):111-6. PubMed ID: 2977405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of thyroid hormones in the pathogenesis of myocardial hypertrophy].
    Popova N; Kolarova R; Zakharieva B; Milanov S; Afar Ia
    Eksp Med Morfol; 1985; 24(4):1-6. PubMed ID: 2938928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.